STAT3 promotes IFNγ/TNFα-induced muscle wasting in an NF-κB-dependent and IL-6-independent manner

Jennifer F Ma1, Brenda J Sanchez1, Derek T Hall1

  • 1Department of Biochemistry, Rosalind and Morris Goodman Cancer Centre, McGill University, Montreal, QC, Canada.

Insights

Interferon gamma (IFNγ) and Tumor Necrosis Factor alpha (TNFα) activate STAT3 independently of Interleukin-6 (IL-6), revealing a new pathway in cancer cachexia.

Area of Science:

  • Oncology
  • Molecular Biology
  • Physiology

Background:

  • Cachexia is a complex syndrome of involuntary muscle wasting in late-stage cancer.
  • Cytokines like IL-6, IFNγ, and TNFα are implicated, but their collaborative mechanisms in muscle atrophy are unclear.

Purpose of the Study:

  • To investigate the collaborative roles of IFNγ, TNFα, and IL-6 in STAT3-mediated muscle wasting.
  • To elucidate the molecular pathways linking these cytokines to muscle atrophy.

Main Methods:

  • In vitro and in vivo studies were conducted.
  • Investigated the phosphorylation of STAT3 and its interaction with NF-κB.
  • Analyzed the activation of the iNOS/NO pathway.

Main Results:

  • IFNγ/TNFα activate JAK kinases, leading to STAT3 phosphorylation at Y705 in muscle fibers, independent of IL-6.
  • Phosphorylated STAT3 (pY-STAT3) forms a complex with NF-κB.
  • This complex is imported into the nucleus, activating the iNOS gene and the iNOS/NO pathway.

Conclusions:

  • STAT3 and NF-κB collaborate in response to IFNγ/TNFα signaling.
  • This cooperation promotes the expression of pro-cachectic genes, offering potential therapeutic targets.
  • Identifies a novel IL-6-independent mechanism in cancer cachexia pathogenesis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K